Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05922514 · ClinicalTrials.gov registry record
A Clinical Registry of Spontaneous Intracranial Hypotension
A clinical trial of Spontaneous Intracranial Hypotension, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05922514 is a study of Spontaneous Intracranial Hypotension that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05922514, a study of Spontaneous Intracranial Hypotension, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine the efficacy of paraspinal vein embolization for treatment of digital subtraction myelography (DSM) or CT myelography (CTM) confirmed cerebrospinal fluid (CSF)-venous fistulas so that researchers can inform the development and design of future clinical trials of this technique.
Conditions Studied
Interventions
- PROCEDURE Transvenous Embolization of Cerebrospinal Fluid-Venous Fistula
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-06-18 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05922514
The ClinicalTrials.gov registry entry for NCT05922514 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spontaneous Intracranial Hypotension appearing as the primary indexed condition, and to 1 intervention - of which Transvenous Embolization of Cerebrospinal Fluid-Venous Fistula is the first listed.
NCT05922514 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05922514 about?
NCT05922514 is a clinical study titled "A Clinical Registry of Spontaneous Intracranial Hypotension". The purpose of this research is to determine the efficacy of paraspinal vein embolization for treatment of digital subtraction myelography (DSM) or CT myelography (CTM) confirmed cerebrospinal fluid (CSF)-venous fistulas so that researchers can inform the development and design of future clinical tr...
What is the current status of trial NCT05922514?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-06-18. Estimated completion is 2026-07.
What conditions does trial NCT05922514 study?
This clinical trial studies the following conditions: Spontaneous Intracranial Hypotension.
What interventions are being tested in trial NCT05922514?
The interventions under investigation include: Transvenous Embolization of Cerebrospinal Fluid-Venous Fistula (PROCEDURE).
Who is sponsoring clinical trial NCT05922514?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05922514 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.